Renalytix Plc
Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for clinical management of kidney diseases in Europe and the United States. It offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics, and personalized patient data from … Read more
Renalytix Plc (RNLXY) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2024: 4.746x
Based on the latest financial reports, Renalytix Plc (RNLXY) has a cash flow conversion efficiency ratio of 4.746x as of December 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-6.50 Million) by net assets ($-1.37 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Renalytix Plc - Cash Flow Conversion Efficiency Trend (2021–2025)
This chart illustrates how Renalytix Plc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Renalytix Plc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Renalytix Plc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Kudelski S.A.
LSE:0QNQ
|
-0.143x |
|
Rani Therapeutics Holdings Inc
NASDAQ:RANI
|
0.423x |
|
Phoenix Asia Holdings Limited Ordinary Shares
NASDAQ:PHOE
|
0.031x |
|
Nivika Fastigheter AB Series B
ST:NIVI-B
|
0.027x |
|
GENOR BIOPHARMA DL-00002
F:67N0
|
N/A |
|
OPTGF
PINK:OPTGF
|
N/A |
|
Unggul Indah Cahaya Tbk
JK:UNIC
|
0.088x |
|
Keding Enterprises Co Ltd
TW:6655
|
0.025x |
Annual Cash Flow Conversion Efficiency for Renalytix Plc (2021–2025)
The table below shows the annual cash flow conversion efficiency of Renalytix Plc from 2021 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | $-7.00 Million | $-17.90 Million | 2.557x | -32.60% |
| 2024-06-30 | $-7.85 Million | $-29.80 Million | 3.794x | +177.55% |
| 2023-06-30 | $6.97 Million | $-34.09 Million | -4.892x | -226.06% |
| 2022-06-30 | $30.61 Million | $-45.92 Million | -1.500x | -479.31% |
| 2021-06-30 | $95.10 Million | $-24.63 Million | -0.259x | -- |